Abstract
GOALS: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. BACKGROUND: There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns. STUDY: Patients enrolled in a population-based surveillance study of persons newly diagnosed with CLD between 1999 and 2001 were asked about current use of CAM specifically for CLD. Sociodemographic and clinical information was obtained from interviews and medical records. Predictors of CAM use were examined using univariate and multivariate logistic regression analysis. RESULTS: Of the 1040 participants, 284 (27.3%) reported current use of at least 1 of 3 CAM therapies of interest. Vitamins or other dietary supplements were the most commonly used therapy, reported by 188 (18.1%) patients. This was followed by herbal medicine (175 patients, 16.8%) and homeopathy (16 patients, 1.5%). Several characteristics were found to be independent correlates of CAM use: higher education and family income, certain CLD etiologies (alcohol, hepatitis C, hepatitis C and alcohol, and hepatitis B), and prior hospitalization for CLD. CONCLUSIONS: Use of CAM therapies that have the potential to interact with conventional treatments for CLD was quite common among this population-based sample of patients with CLD. There is a need for patient and practitioner education and communication regarding CAM use in the context of CLD.
| Original language | English (US) |
|---|---|
| Journal | Journal of Clinical Gastroenterology |
| Volume | 44 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2010 |
| Externally published | Yes |
Fingerprint
Keywords
- Chronic liver disease
- Complementary and alternative medicine
- Epidemiology
ASJC Scopus subject areas
- Gastroenterology
Cite this
Complementary and alternative medicine use in chronic liver disease patients. / Ferrucci, Leah M.; Bell, Beth P.; Dhotre, Kathy B.; Manos, M. Michele; Terrault, Norah A.; Zaman, Atif; Murphy, Rosemary C.; Vanness, Grace R.; Thomas, Ann R.; Bialek, Stephanie R.; Desai, Mayur M.; Sofair, Andre N.
In: Journal of Clinical Gastroenterology, Vol. 44, No. 2, 02.2010.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Complementary and alternative medicine use in chronic liver disease patients
AU - Ferrucci, Leah M.
AU - Bell, Beth P.
AU - Dhotre, Kathy B.
AU - Manos, M. Michele
AU - Terrault, Norah A.
AU - Zaman, Atif
AU - Murphy, Rosemary C.
AU - Vanness, Grace R.
AU - Thomas, Ann R.
AU - Bialek, Stephanie R.
AU - Desai, Mayur M.
AU - Sofair, Andre N.
PY - 2010/2
Y1 - 2010/2
N2 - GOALS: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. BACKGROUND: There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns. STUDY: Patients enrolled in a population-based surveillance study of persons newly diagnosed with CLD between 1999 and 2001 were asked about current use of CAM specifically for CLD. Sociodemographic and clinical information was obtained from interviews and medical records. Predictors of CAM use were examined using univariate and multivariate logistic regression analysis. RESULTS: Of the 1040 participants, 284 (27.3%) reported current use of at least 1 of 3 CAM therapies of interest. Vitamins or other dietary supplements were the most commonly used therapy, reported by 188 (18.1%) patients. This was followed by herbal medicine (175 patients, 16.8%) and homeopathy (16 patients, 1.5%). Several characteristics were found to be independent correlates of CAM use: higher education and family income, certain CLD etiologies (alcohol, hepatitis C, hepatitis C and alcohol, and hepatitis B), and prior hospitalization for CLD. CONCLUSIONS: Use of CAM therapies that have the potential to interact with conventional treatments for CLD was quite common among this population-based sample of patients with CLD. There is a need for patient and practitioner education and communication regarding CAM use in the context of CLD.
AB - GOALS: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. BACKGROUND: There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns. STUDY: Patients enrolled in a population-based surveillance study of persons newly diagnosed with CLD between 1999 and 2001 were asked about current use of CAM specifically for CLD. Sociodemographic and clinical information was obtained from interviews and medical records. Predictors of CAM use were examined using univariate and multivariate logistic regression analysis. RESULTS: Of the 1040 participants, 284 (27.3%) reported current use of at least 1 of 3 CAM therapies of interest. Vitamins or other dietary supplements were the most commonly used therapy, reported by 188 (18.1%) patients. This was followed by herbal medicine (175 patients, 16.8%) and homeopathy (16 patients, 1.5%). Several characteristics were found to be independent correlates of CAM use: higher education and family income, certain CLD etiologies (alcohol, hepatitis C, hepatitis C and alcohol, and hepatitis B), and prior hospitalization for CLD. CONCLUSIONS: Use of CAM therapies that have the potential to interact with conventional treatments for CLD was quite common among this population-based sample of patients with CLD. There is a need for patient and practitioner education and communication regarding CAM use in the context of CLD.
KW - Chronic liver disease
KW - Complementary and alternative medicine
KW - Epidemiology
UR - http://www.scopus.com/inward/record.url?scp=75749140935&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=75749140935&partnerID=8YFLogxK
U2 - 10.1097/MCG.0b013e3181b766ed
DO - 10.1097/MCG.0b013e3181b766ed
M3 - Article
C2 - 19779363
AN - SCOPUS:75749140935
VL - 44
JO - Journal of Clinical Gastroenterology
JF - Journal of Clinical Gastroenterology
SN - 0192-0790
IS - 2
ER -